RPL29 (Ribosomal Protein L29) is a component of the large (60S) ribosomal subunit. It is a small, cysteine-rich protein that plays a structural role in ribosome function and is involved in protein synthesis essential for neuronal survival and function 1.
| RPL29 Gene |
|---|
| Symbol | RPL29 |
| Full Name | Ribosomal Protein L29 |
| Aliases | L29, HSU37072 |
| Chromosomal Location | 14q21.3 |
| NCBI Gene ID | 6165 |
| Ensembl ID | ENSG00000137285 |
| UniProt | P47914 |
| Protein Length | 159 amino acids |
RPL29 is a ribosomal protein that contributes to the structural integrity of the 60S ribosomal subunit:
- 60S subunit component: Part of the large ribosomal subunit
- Peptidyl transferase center: Contributes to the catalytic site for peptide bond formation
- Ribosome stability: Helps maintain the structural integrity of the ribosome
- Protein synthesis: Essential for translation of mRNA into protein
- Ribosome assembly: Participates in the assembly of functional ribosomes
- Cellular localization: Cytoplasmic and nucleolar (during assembly)
RPL29 interacts with:
- RPL5, RPL11: Core 60S proteins
- RPL23: Neighboring ribosomal proteins
- eIF4E: Translation initiation factor
Ribosomal dysfunction is a well-documented feature of AD:
- Translation impairment: Global reduction in protein synthesis in AD brain 2
- Ribosome aggregation: Associated with neurofibrillary tangles
- RPL29 expression: Altered in vulnerable brain regions
Dopaminergic neurons are particularly sensitive to translation defects:
- Protein homeostasis: Efficient ribosome function critical for α-synuclein clearance
- ER stress: Ribosome dysfunction contributes to ER stress response
- Mitochondrial function: Translation of mitochondrial proteins affected
- Motor neuron demands: High protein synthesis requirements
- Ribosome stalling: Implicated in ALS pathogenesis
- Stress granules: Ribosomal proteins sequestered in stress granules
| Brain Region |
Expression |
Notes |
| Motor cortex |
High |
Vulnerable in ALS |
| Hippocampus |
High |
Memory consolidation |
| Substantia nigra |
Moderate |
Dopaminergic neurons |
| Cerebellum |
Moderate |
Purkinje cells |
- Translation enhancers: Small molecules to improve ribosomal function
- Gene therapy: Restore expression of ribosomal proteins
- Stress granule modulators: Prevent aberrant sequestration
- Cerebrospinal fluid levels of ribosomal proteins as biomarkers
- Translation efficiency as a therapeutic response marker
flowchart TD
A["60S Ribosomal Subunit<br/>including RPL29"] --> B["Active Translation"]
B --> C["Normal Protein<br/>Synthesis"]
D["Cellular Stress"] --> E["Translation<br/>Inhibition"]
E --> F["Stress Granule<br/>Formation"]
F --> G["mRNA<br/>Sequestration"]
H["Neurodegenerative<br/>Disease"] --> I["Protein<br/>Homeostasis Loss"]
I --> J["Protein<br/>Aggregation"]
J --> K["Proteotoxicity"]
C --> I
style A fill:#e1f5fe
style H fill:#ffcdd2
style I fill:#ef9a9a
style K fill:#ef9a9a